ECT2 Blocking Peptide

Product Type

Proteins
Product Subtype

Blocking Peptides
Research Area

Cancer
Tag Conjugate

PECGRQSLVELLIRPVQRLPSVALLLNDLKKHTADENPDKSTLEKAIGSL
Type1

Synthetic
Form Buffer

Lyophilized powder. Add 100ul of distilled water for a final peptide concentration is 1 mg/ml.
Storage

Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
Applications

WB, IHC
Shipping Info

Blue Ice
Test

You can block the antibody by the specific target amino acid sequence of peptide.
Properties

blocking peptide
Description

Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.

Gene target

ECT2
Gene symbol

ECT2
Short name

ECT2 Blocking Peptide
Technique

blocking peptide, Blocking, peptide, blocking peptides, fitzgerald made this blocking amino acid sequence or peptide to block the gene target in a volume of 1. For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear. This is called a negative control by blocking the WB antibody. peptides
Alternative name

epithelial cell transforming sequence 2 oncogene inhibiting short protein sequence
Alternative technique

control, peptides
Alternative to gene target

epithelial cell transforming sequence 2 oncogene, ARHGEF31, ECT2 and IDBG-65239 and ENSG00000114346 and 1894, protein homodimerization activity, nuclei, Ect2 and IDBG-134125 and ENSMUSG00000027699 and 13605, BT.28366 and IDBG-636155 and ENSBTAG00000023814 and 100849477,504746